EXTENDICARE INC (EXE.CA) Stock Fundamental Analysis
Canada - Toronto Stock Exchange - TSX:EXE - CA30224T8639 - Common Stock
22.36 CAD
+0.13 (+0.58%)
EXE gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 14 industry peers in the Health Care Providers & Services industry. EXE has an excellent profitability rating, but there are some minor concerns on its financial health. EXE is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
EXE had positive earnings in the past year.
In the past year EXE had a positive cash flow from operations.
EXE had positive earnings in each of the past 5 years.
In the past 5 years EXE always reported a positive cash flow from operatings.
1.2 Ratios
With an excellent Return On Assets value of 10.41%, EXE belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
The Return On Equity of EXE (55.53%) is better than 92.86% of its industry peers.
Looking at the Return On Invested Capital, with a value of 18.54%, EXE belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for EXE is above the industry average of 7.27%.
The last Return On Invested Capital (18.54%) for EXE is above the 3 year average (11.40%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.41% | ||
| ROE | 55.53% | ||
| ROIC | 18.54% |
ROA(3y)8.13%
ROA(5y)6.26%
ROE(3y)56.07%
ROE(5y)44.35%
ROIC(3y)11.4%
ROIC(5y)10.15%
1.3 Margins
EXE has a better Profit Margin (5.72%) than 85.71% of its industry peers.
EXE's Profit Margin has improved in the last couple of years.
EXE has a better Operating Margin (8.22%) than 78.57% of its industry peers.
EXE's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 14.15%, EXE is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
EXE's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.22% | ||
| PM (TTM) | 5.72% | ||
| GM | 14.15% |
OM growth 3Y21.21%
OM growth 5Y10.26%
PM growth 3Y73.29%
PM growth 5Y15.22%
GM growth 3Y6.44%
GM growth 5Y3.11%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so EXE is creating value.
EXE has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, EXE has less shares outstanding
Compared to 1 year ago, EXE has an improved debt to assets ratio.
2.2 Solvency
EXE has an Altman-Z score of 3.31. This indicates that EXE is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 3.31, EXE belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
The Debt to FCF ratio of EXE is 3.39, which is a good value as it means it would take EXE, 3.39 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.39, EXE is in the better half of the industry, outperforming 78.57% of the companies in the same industry.
A Debt/Equity ratio of 1.94 is on the high side and indicates that EXE has dependencies on debt financing.
The Debt to Equity ratio of EXE (1.94) is worse than 64.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.94 | ||
| Debt/FCF | 3.39 | ||
| Altman-Z | 3.31 |
ROIC/WACC2.47
WACC7.5%
2.3 Liquidity
A Current Ratio of 0.81 indicates that EXE may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.81, EXE is in line with its industry, outperforming 57.14% of the companies in the same industry.
A Quick Ratio of 0.81 indicates that EXE may have some problems paying its short term obligations.
EXE has a better Quick ratio (0.81) than 64.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.81 | ||
| Quick Ratio | 0.81 |
3. Growth
3.1 Past
EXE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 52.52%, which is quite impressive.
The Earnings Per Share has been growing by 22.74% on average over the past years. This is a very strong growth
The Revenue has grown by 11.59% in the past year. This is quite good.
The Revenue has been growing slightly by 5.31% on average over the past years.
EPS 1Y (TTM)52.52%
EPS 3Y92.12%
EPS 5Y22.74%
EPS Q2Q%65.04%
Revenue 1Y (TTM)11.59%
Revenue growth 3Y7.91%
Revenue growth 5Y5.31%
Sales Q2Q%22.62%
3.2 Future
EXE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.75% yearly.
EXE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.83% yearly.
EPS Next Y34.49%
EPS Next 2Y21.44%
EPS Next 3Y19.11%
EPS Next 5Y9.75%
Revenue Next Year16.1%
Revenue Next 2Y17.44%
Revenue Next 3Y14.36%
Revenue Next 5Y10.83%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 21.50, which indicates a rather expensive current valuation of EXE.
Compared to the rest of the industry, the Price/Earnings ratio of EXE indicates a somewhat cheap valuation: EXE is cheaper than 78.57% of the companies listed in the same industry.
EXE's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.56.
A Price/Forward Earnings ratio of 19.00 indicates a rather expensive valuation of EXE.
Based on the Price/Forward Earnings ratio, EXE is valued a bit cheaper than 78.57% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.79. EXE is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.5 | ||
| Fwd PE | 19 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, EXE is valued a bit cheaper than the industry average as 78.57% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of EXE indicates a somewhat cheap valuation: EXE is cheaper than 64.29% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.8 | ||
| EV/EBITDA | 12.34 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EXE has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as EXE's earnings are expected to grow with 19.11% in the coming years.
PEG (NY)0.62
PEG (5Y)0.95
EPS Next 2Y21.44%
EPS Next 3Y19.11%
5. Dividend
5.1 Amount
EXE has a Yearly Dividend Yield of 2.27%.
Compared to an average industry Dividend Yield of 1.18, EXE pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 1.87, EXE pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.27% |
5.2 History
The dividend of EXE has a limited annual growth rate of 2.79%.
EXE has paid a dividend for at least 10 years, which is a reliable track record.
EXE has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)2.79%
Div Incr Years1
Div Non Decr Years3
5.3 Sustainability
45.22% of the earnings are spent on dividend by EXE. This is a bit on the high side, but may be sustainable.
EXE's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP45.22%
EPS Next 2Y21.44%
EPS Next 3Y19.11%
TSX:EXE (12/12/2025, 7:00:00 PM)
22.36
+0.13 (+0.58%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners28.52%
Inst Owner ChangeN/A
Ins Owners13.12%
Ins Owner ChangeN/A
Market Cap1.87B
Revenue(TTM)1.59B
Net Income(TTM)91.00M
Analysts75.56
Price Target23.72 (6.08%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.27% |
Yearly Dividend0.48
Dividend Growth(5Y)2.79%
DP45.22%
Div Incr Years1
Div Non Decr Years3
Ex-Date
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)39.33%
PT rev (3m)42.64%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)8.64%
EPS NY rev (3m)7.59%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)3.62%
Revenue NY rev (3m)4.52%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.5 | ||
| Fwd PE | 19 | ||
| P/S | 1.18 | ||
| P/FCF | 18.8 | ||
| P/OCF | 12.27 | ||
| P/B | 11.44 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.34 |
EPS(TTM)1.04
EY4.65%
EPS(NY)1.18
Fwd EY5.26%
FCF(TTM)1.19
FCFY5.32%
OCF(TTM)1.82
OCFY8.15%
SpS18.97
BVpS1.96
TBVpS-0.41
PEG (NY)0.62
PEG (5Y)0.95
Graham Number6.76
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.41% | ||
| ROE | 55.53% | ||
| ROCE | 24.53% | ||
| ROIC | 18.54% | ||
| ROICexc | 26.92% | ||
| ROICexgc | 58.63% | ||
| OM | 8.22% | ||
| PM (TTM) | 5.72% | ||
| GM | 14.15% | ||
| FCFM | 6.27% |
ROA(3y)8.13%
ROA(5y)6.26%
ROE(3y)56.07%
ROE(5y)44.35%
ROIC(3y)11.4%
ROIC(5y)10.15%
ROICexc(3y)15.38%
ROICexc(5y)13.52%
ROICexgc(3y)24.33%
ROICexgc(5y)19.82%
ROCE(3y)15.09%
ROCE(5y)13.42%
ROICexgc growth 3Y72.34%
ROICexgc growth 5Y37.48%
ROICexc growth 3Y55.61%
ROICexc growth 5Y29.1%
OM growth 3Y21.21%
OM growth 5Y10.26%
PM growth 3Y73.29%
PM growth 5Y15.22%
GM growth 3Y6.44%
GM growth 5Y3.11%
F-Score6
Asset Turnover1.82
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.94 | ||
| Debt/FCF | 3.39 | ||
| Debt/EBITDA | 1.91 | ||
| Cap/Depr | 150.97% | ||
| Cap/Sales | 3.34% | ||
| Interest Coverage | 9.89 | ||
| Cash Conversion | 92.12% | ||
| Profit Quality | 109.55% | ||
| Current Ratio | 0.81 | ||
| Quick Ratio | 0.81 | ||
| Altman-Z | 3.31 |
F-Score6
WACC7.5%
ROIC/WACC2.47
Cap/Depr(3y)281.27%
Cap/Depr(5y)221.87%
Cap/Sales(3y)7.03%
Cap/Sales(5y)5.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)52.52%
EPS 3Y92.12%
EPS 5Y22.74%
EPS Q2Q%65.04%
EPS Next Y34.49%
EPS Next 2Y21.44%
EPS Next 3Y19.11%
EPS Next 5Y9.75%
Revenue 1Y (TTM)11.59%
Revenue growth 3Y7.91%
Revenue growth 5Y5.31%
Sales Q2Q%22.62%
Revenue Next Year16.1%
Revenue Next 2Y17.44%
Revenue Next 3Y14.36%
Revenue Next 5Y10.83%
EBIT growth 1Y30.7%
EBIT growth 3Y30.79%
EBIT growth 5Y16.11%
EBIT Next Year10.76%
EBIT Next 3Y17.06%
EBIT Next 5Y9.15%
FCF growth 1Y199.78%
FCF growth 3YN/A
FCF growth 5Y53.33%
OCF growth 1Y343.54%
OCF growth 3Y31.32%
OCF growth 5Y26.02%
EXTENDICARE INC / EXE.CA FAQ
What is the fundamental rating for EXE stock?
ChartMill assigns a fundamental rating of 6 / 10 to EXE.CA.
Can you provide the valuation status for EXTENDICARE INC?
ChartMill assigns a valuation rating of 6 / 10 to EXTENDICARE INC (EXE.CA). This can be considered as Fairly Valued.
What is the profitability of EXE stock?
EXTENDICARE INC (EXE.CA) has a profitability rating of 8 / 10.
Can you provide the PE and PB ratios for EXE stock?
The Price/Earnings (PE) ratio for EXTENDICARE INC (EXE.CA) is 21.5 and the Price/Book (PB) ratio is 11.44.
What is the financial health of EXTENDICARE INC (EXE.CA) stock?
The financial health rating of EXTENDICARE INC (EXE.CA) is 5 / 10.